logo
episode-header-image
Apr 2019
47m 36s

#26: All Netflix and No Chill

The Wall Street Journal
About this episode

David, Joanna and Christopher talk about the bizarre non-launch and Joanna's non-review of the Samsung Galaxy Fold, and what it means for the future of foldable phones. Then, WSJ reporter Shalini Ramachandran comes on to talk about her story on how Netflix and other streaming services are putting a serious dent into peoples' sex lives. In this week's Today I Learned, Christopher explains why nobody believes Elon Musk's statements about robot taxis and fancy new chips. Finally, David interviews Oleg Stavitsky, the CEO of a company called Endel that makes algorithmically-generated soundtracks for your life, about how a computer can learn to make music and whether every aspiring rock star should be nervous.

Up next
Aug 2019
#42: Looking Back ... to the Future (of Everything)
In a special encore presentation, a look back at the WSJ Future of Everything Festival, the three-day event filled with speakers, panels and demos showing us where the world is going-for better or worse. Lots of Hyperloop, self-driving vehicles, AR and VR, good AI, bad AI... all ... Show More
51m 31s
Aug 2019
#41: Fancy Phones and Fancier Credit Cards
David and Joanna discuss the new Samsung Galaxy Note 10, the phone for people who get stuff done. (Stuff. Not other words.) It has a new stylus and some new software and a bunch of new cameras. Later, WSJ reporter Liz Hoffman comes in to talk about the new Apple Card, which David ... Show More
50m 5s
Aug 2019
#40: Where Are the Good Netflix Movies?
David, Joanna and Christopher start by discussing the future of retail, which at least partly involves all those brands you see in Instagram ads suddenly showing up in a store near you. (The gang also learns a new word: "omnichannel.") Next, WSJ reporter RT Watson hops on to disc ... Show More
42m 57s
Recommended Episodes
Apr 2025
RFK Jr's cuts to US health
Robert F. Kennedy Jr. has promised to streamline what he calls a bloated health bureaucracy. Job cuts at the FDA, CDC and NIH this week saw pharma stocks drop and raised concerns about the country's readiness to fight health threats like the measles outbreak. On this episode of R ... Show More
21m 3s